Adzhubei I., Jordan D. M. and Sunyaev S. R. 2013 Predicting functional effect of human missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet. 76, 7–20.

Google Scholar 

Afgan E., Baker D., van den Beek M., Blankenberg D., Bouvier D., Čech M. et al. 2016 The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update. Nucleic Acids Res. 44, 3–10.

Article  Google Scholar 

Amberger J. S., Bocchini C. A., Schiettecatte F., Scott A. F. and Hamosh A. 2015 OMIM. org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders. J. Nucleic Acids 43, 789–798.

Article  Google Scholar 

Baker P. R., Friederich M. W., Swanson M. A., Shaikh T., Bhattacharya K., Scharer G. H. et al. 2014 Variant non ketotic hyperglycinemia is caused by mutations in LIAS, BOLA3 and the novel gene GLRX5. Brain 137, 366–379.

Article  PubMed  Google Scholar 

Bhattacharya S., Srinivasan K., Abdisalaam S., Su F., Raj P., Dozmorov I. et al. 2017 RAD51 interconnects between DNA replication, DNA repair and immunity. Nucleic Acids Res. 45, 4590–4605.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Biswas S., Manekar S. and Bakshi S. R. 2023 A case study on PPM1D and 9 other shared germline alterations in a family. Asian Pac. J. Cancer Prev. 24, 2129–2134.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown G. K., Otero L. J., LeGris M. and Brown R. M. 1994 Pyruvate dehydrogenase deficiency. J. Med. Genet. 31, 875–879.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bueno-Martínez E., Sanoguera-Miralles L., Valenzuela-Palomo A., Lorca V., Gómez-Sanz A., Carvalho S. et al. 2021 RAD51D Aberrant splicing in breast cancer: identification of splicing regulatory elements and minigene-based evaluation of 53 DNA variants. J. Cancer. 13, 2845.

Article  Google Scholar 

Cai Y., He Q., Liu W., Liang Q., Peng B., Li J. et al. 2022 Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers. Front. Oncol. 12, 952129.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Colonne C. K., Favaloro E. J. and Pasalic L. 2022 The intriguing connections between Von Willebrand Factor, ADAMTS13 and cancer. Healthcare. 10, 557.

Article  PubMed  PubMed Central  Google Scholar 

Davydov E. V., Goode D. L., Sirota M., Cooper G. M., Sidow A. and Batzoglou S. 2010 Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput. Biol. 6, e1001025.

Article  PubMed  PubMed Central  Google Scholar 

de Vries L., Behar D. M., Smirin-Yosef P., Lagovsky I., Tzur S. and Basel-Vanagaite L. 2014 Exome sequencing reveals SYCE1 mutation associated with autosomal recessive primary ovarian insufficiency. J. Clin. Endocrinol. Metab. 99, 2129–2132.

Article  Google Scholar 

Fan C., Zhang J., Ouyang T., Li J., Wang T., Fan Z. et al. 2018 RAD50 germline mutations are associated with poor survival in BRCA1/2-negative breast cancer patients. Int. J. Cancer. 143, 1935–1942.

Article  CAS  PubMed  Google Scholar 

Gardner S. A., Weymouth K. S., Kelly W. S., Bogdanova E., Chen W., Lupu D. et al. 2018 Evaluation of a 27-gene inherited cancer panel across 630 consecutive patients referred for testing in a clinical diagnostic laboratory. Hered. Cancer Clin. Pract. 16, 1–10.

Article  PubMed  PubMed Central  Google Scholar 

Gudmundsson S., Singer-Berk M., Watts N. A., Phu W., Goodrich J. K., Solomonson M. et al. 2022 Variant interpretation using population databases: lessons from GnomAD. Hum. Mutat. 43, 1012–1030.

Article  PubMed  Google Scholar 

Henkel J., Laner A., Locher M., Wohlfrom T., Neitzel B., Becker K. et al. 2023 Diagnostic yield and clinical relevance of expanded germline genetic testing for nearly 7000 suspected HBOC patients. Eur. J. Hum. Genet. 31, 925–930.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hosoya N. and Miyagawa K. 2021 Synaptonemal complex proteins modulate the level of genome integrity in cancers. Cancer Sci. 112, 989–996.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ji K., Ao S., He L., Zhang L., Feng L. and Lyu G. 2020 Characteristics of cancer susceptibility genes mutations in 282 patients with gastric adenocarcinoma. Chin. J. Cancer Res. 32, 508–515.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Köhler S., Carmody L., Vasilevsky N., Jacobsen J. O. B., Danis D., Gourdine J. P. et al. 2019 Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources. J. Nucleic Acids. 47, 1018–1027.

Article  Google Scholar 

Landrum M. J., Chitipiralla S., Brown G. R., Chen C., Gu B., Hart J. et al. 2020 ClinVar: improvements to accessing data. J. Nucleic Acids. 48, 835–844.

Article  Google Scholar 

Li Y., Li X., Li X., Zhong Y., Ji Y., Yu D. et al. 2016 PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence. Oncotarget. 7, 53837–53852.

Article  PubMed  PubMed Central  Google Scholar 

Liu Z., Yu M., Fei B., Fang X., Ma T. and Wang D. 2018 miR-21-5p targets PDHA1 to regulate glycolysis and cancer progression in gastric cancer. Oncol Rep. 40, 2955–2963.

CAS  PubMed  Google Scholar 

Loveday C., Turnbull C., Ramsay E., Hughes D., Ruark E., Frankum J. R. et al. 2011 Germline mutations in RAD51D confer susceptibility to ovarian cancer. Nat. Genet. 43, 879–882.

Article  CAS  PubMed  Google Scholar 

Lowe D. G. 1999 Object recognition from local scale-invariant features. In proceedings of the seventh IEEE international conference on computer vision 2, 1150–1157.

Maor-Sagie E., Cinnamon Y., Yaacov B., Shaag A., Goldsmidt H., Zenvirt S. et al. 2015 Deleterious mutation in SYCE1 is associated with non-obstructive azoospermia. J. Assist. Reprod. Gene. 32, 887–891.

Article  Google Scholar 

Mayr J. A., Zimmermann F. A., Fauth C., Bergheim C., Meierhofer D., Radmayr D. et al. 2011 Lipoic acid synthetase deficiency causes neonatal-onset epilepsy, defective mitochondrial energy metabolism, and glycine elevation. Am. J. Hum. Genet. 89, 792–797.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McKenna A., Hanna M., Banks E., Sivachenko A., Cibulskis K., Kernytsky A. et al. 2010 The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297–1303.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rajkumar T., Soumittra N., Nancy N. K., Swaminathan R., Sridevi V. and Shanta V. 2003 BRCA1, BRCA2 and CHEK2 (1100 del C) germline mutations in hereditary breast and ovarian cancer families in South India. Asian Pac. J. Cancer Prev. 4, 203–208.

PubMed  Google Scholar 

Ramani R., Krumholz K., Huang Y. F. and Siepel A. 2019 PhastWeb: a web interface for evolutionary conservation scoring of multiple sequence alignments using phastCons and phyloP. J. Bioinform. 35, 2320–2322.

Article  CAS  Google Scholar 

Rivera B., Di Iorio M., Frankum J., Nadaf J., Fahiminiya S., Arcand S. L. et al. 2017 Functionally null RAD51D missense mutation associates strongly with ovarian carcinoma. Cancer Res. 77, 4517–4529.

Article  CAS  PubMed  Google Scholar 

Robinson J. T., Thorvaldsdóttir H., Winckler W., Guttman M., Lander E. S., Getz G. et al. 2011 Integrative genomics viewer. Nat. Biotechnol. 29, 24–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samadder N. J., Riegert-Johnson D., Boardman L., Rhodes D., Wick M., Okuno S. et al. 2021 Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome. Jamaoncol. 7, 230–237.

Google Scholar 

Sayers E. W., Bolton E. E., Brister J. R., Canese K., Chan J., Comeau D. C. et al. 2022 Database resources of the national center for biotechnology information. J. Nucleic Acids. 50, 20–26.

Article  Google Scholar 

Sharma Bhai P., Sharma D., Saxena R. and Verma I. C. 2017 Next-generation sequencing reveals a nonsense mutation (p. Arg364Ter) in MRE11A gene in an Indian Patient with familial breast cancer. Breast Care (basel) 12, 114–116.

Article  PubMed  Google Scholar